The Purple Book: Understanding Biosimilars and Interchangeability from the FDA
- Dorian Wakefield
- 12 Jan 2026
- Pharmacy
The FDA's Purple Book is the official guide to biosimilars and interchangeable biologics in the U.S. Learn how it works, what interchangeability really means, and why state laws matter more than you think.
View More